Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M405009200 on December 2, 2004

J. Biol. Chem., Vol. 280, Issue 9, 8031-8040, March 4, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/9/8031    most recent
M405009200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baranova, I. N.
Right arrow Articles by Patterson, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baranova, I. N.
Right arrow Articles by Patterson, A. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Serum Amyloid A Binding to CLA-1 (CD36 and LIMPII Analogous-1) Mediates Serum Amyloid A Protein-induced Activation of ERK1/2 and p38 Mitogen-activated Protein Kinases*

Irina N. Baranova{ddagger}, Tatyana G. Vishnyakova§, Alexander V. Bocharov{ddagger}, Roger Kurlander{ddagger}, Zhigang Chen§, Michael L. Kimelman{ddagger}, Alan T. Remaley§, Gyorgy Csako{ddagger}, Fairwell Thomas§, Thomas L. Eggerman{ddagger}, and Amy P. Patterson§||

From the {ddagger}Department of Laboratory Medicine, W. G. Magnuson Clinical Center, §NHLBI, and the Division of Diabetes, Endocrinology and Metabolic Diseases, NIDDK, National Institutes of Health, Bethesda, Maryland 20892

Serum amyloid A protein (SAA) is an acute-phase reactant, known to mediate pro-inflammatory cellular responses. This study reports that CLA-1 (CD36 and LIMPII Analogous-1; human orthologue of the Scavenger Receptor Class B Type I (SR-BI)) mediates SAA uptake and downstream SAA signaling. Flow cytometry experiments revealed more than a 5-fold increase of Alexa-488 SAA uptake in HeLa cells stably transfected with CLA-1. Alexa 488-HDL uptake directly correlated with SAA uptake when determined in several CLA-1 stably transfected HeLa cell clones expressing various levels of CLA-1. SAA directly binds to CLA-1 as determined by cross-linking and colocalization of anti-CLA-1 antibody with SAA. SAA was co-internalized with transferrin to the endocytic recycling compartment pointing to a potential site of SAA metabolism. Alexa-488 SAA uptake in the CLA-1-overexpressing HeLa cells, as well as in THP-1 monocyte cell line, can be efficiently blocked by unlabeled SAA, high density lipoprotein, and other CLA-1 ligands. At the same time, markedly enhanced levels of phosphorylation of the mitogen-activated protein kinases (MAPKs), ERK1/2, and p38, were observed in cells stably transfected with CLA-1 cells following SAA stimulation when compared with mock transfected cells. The levels of the SAA-induced interleukin-8 (IL-8) secretion by CLA-1-overexpressing cells also significantly exceeded (5- to 10-fold) those detected for control cells. Synthetic amphipathic peptides possessing a structural {alpha}-helical motif inhibited SAA-induced activation of both MAPKs and IL-8 secretion in THP-1 cells. The results of this study demonstrate for the first time that CLA-1 functions as an endocytic SAA receptor and is involved in SAA-mediated cell signaling events associated with the immune-related and inflammatory effects of SAA.


Received for publication, May 5, 2004 , and in revised form, November 19, 2004.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Office of Biotechnology Activities, Office of Science Policy, Office of the Director, National Institutes of Health, 6705 Rockledge Dr., St. 750, Rockville, MD 20892-7985. Tel.: 301-496-9838; Fax: 301-496-9839; E-mail: pattersa{at}od.nih.gov (to A. P. P.) and abocharov{at}mail.cc.nih.gov (to A. V. B.).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
R. D. Ye, F. Boulay, J. M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C. N. Serhan, and P. M. Murphy
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
Pharmacol. Rev., June 1, 2009; 61(2): 119 - 161.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. L. He, J. Zhou, C. Z. Hanson, J. Chen, N. Cheng, and R. D. Ye
Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2
Blood, January 8, 2009; 113(2): 429 - 437.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Wang, H. Chai, Z. Wang, P. H. Lin, Q. Yao, and C. Chen
Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2399 - H2408.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Cheng, R. He, J. Tian, P. P. Ye, and R. D. Ye
Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A
J. Immunol., July 1, 2008; 181(1): 22 - 26.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W.-H. Wang, L. G. McNatt, I.-H. Pang, P. E. Hellberg, J. H. Fingert, M. D. McCartney, and A. F. Clark
Increased Expression of Serum Amyloid A in Glaucoma and Its Effect on Intraocular Pressure
Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1916 - 1923.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Sandri, D. Rodriguez, E. Gomes, H. P. Monteiro, M. Russo, and A. Campa
Is serum amyloid A an endogenous TLR4 agonist?
J. Leukoc. Biol., May 1, 2008; 83(5): 1174 - 1180.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. Bjorkman, J. Karlsson, A. Karlsson, M.-J. Rabiet, F. Boulay, H. Fu, J. Bylund, and C. Dahlgren
Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1
J. Leukoc. Biol., February 1, 2008; 83(2): 245 - 253.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Christenson, L. Bjorkman, C. Tangemo, and J. Bylund
Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1
J. Leukoc. Biol., January 1, 2008; 83(1): 139 - 148.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Zhao, S. Zhou, and C.-K. Heng
Impact of Serum Amyloid A on Tissue Factor and Tissue Factor Pathway Inhibitor Expression and Activity in Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., July 1, 2007; 27(7): 1645 - 1650.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Cai, L. Cai, J. Jiang, K.-S. Chang, D. R. van der Westhuyzen, and G. Luo
Human Serum Amyloid A Protein Inhibits Hepatitis C Virus Entry into Cells
J. Virol., June 1, 2007; 81(11): 6128 - 6133.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Zhang, A. M. Ahmed, N. McFarlane, C. Capone, D. R. Boreham, R. Truant, S. A. Igdoura, and B. L. Trigatti
Regulation of SR-BI-mediated selective lipid uptake in Chinese hamster ovary-derived cells by protein kinase signaling pathways
J. Lipid Res., February 1, 2007; 48(2): 405 - 416.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Cai, C. Song, I. Endoh, J. Goyette, W. Jessup, S. B. Freedman, H. P. McNeil, and C. L. Geczy
Serum Amyloid A Induces Monocyte Tissue Factor
J. Immunol., February 1, 2007; 178(3): 1852 - 1860.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. G. Vishnyakova, R. Kurlander, A. V. Bocharov, I. N. Baranova, Z. Chen, M. S. Abu-Asab, M. Tsokos, D. Malide, F. Basso, A. Remaley, et al.
CLA-1 and its splicing variant CLA-2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells
PNAS, November 7, 2006; 103(45): 16888 - 16893.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-S. Lee, S.-A. Yoo, C.-S. Cho, P.-G. Suh, W.-U. Kim, and S. H. Ryu
Serum Amyloid A Binding to Formyl Peptide Receptor-Like 1 Induces Synovial Hyperplasia and Angiogenesis
J. Immunol., October 15, 2006; 177(8): 5585 - 5594.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. He, L. W. Shepard, J. Chen, Z. K. Pan, and R. D. Ye
Serum Amyloid A Is an Endogenous Ligand That Differentially Induces IL-12 and IL-23
J. Immunol., September 15, 2006; 177(6): 4072 - 4079.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Shah, R. Hari-Dass, and J. G. Raynes
Serum amyloid A is an innate immune opsonin for Gram-negative bacteria
Blood, September 1, 2006; 108(5): 1751 - 1757.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Abe-Dohmae, K. H. Kato, Y. Kumon, W. Hu, H. Ishigami, N. Iwamoto, M. Okazaki, C.-A. Wu, M. Tsujita, K. Ueda, et al.
Serum amyloid A generates high density lipoprotein with cellular lipid in an ABCA1- or ABCA7-dependent manner
J. Lipid Res., July 1, 2006; 47(7): 1542 - 1550.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. R. van der Westhuyzen, L. Cai, M. C. de Beer, and F. C. de Beer
Serum Amyloid A Promotes Cholesterol Efflux Mediated by Scavenger Receptor B-I
J. Biol. Chem., October 28, 2005; 280(43): 35890 - 35895.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Hari-Dass, C. Shah, D. J. Meyer, and J. G. Raynes
Serum Amyloid A Protein Binds to Outer Membrane Protein A of Gram-negative Bacteria
J. Biol. Chem., May 13, 2005; 280(19): 18562 - 18567.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement